QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
Log in
NYSEAMERICAN:CTEK

CynergisTek Stock Forecast, Price & News

$1.03
+0.03 (+3.00 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.00
Now: $1.03
$1.05
50-Day Range N/A
52-Week Range
$0.96
Now: $1.03
$4.04
Volume53,060 shs
Average Volume72,390 shs
Market Capitalization$10.91 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cynergistek, Inc. provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program. It also serves financial institutions, and gaming and other industries. The company was formerly known as Auxilio, Inc. and changed its name to Cynergistek, Inc. in September 2017. Cynergistek, Inc. is based in Mission Viejo, California.
Read More
CynergisTek logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.10 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Diversified Machinery
Sub-IndustryN/A
Current SymbolNYSEAMERICAN:CTEK
Previous SymbolNYSEMKT:CTEK
CUSIPN/A
Phone949-614-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees292
Market Cap$10.91 million
Next Earnings Date11/9/2020 (Estimated)
OptionableNot Optionable
$1.03
+0.03 (+3.00 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTEK News and Ratings via Email

Sign-up to receive the latest news and ratings for CTEK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CynergisTek (NYSEAMERICAN:CTEK) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of CynergisTek?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CynergisTek in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for CynergisTek
.

When is CynergisTek's next earnings date?

CynergisTek is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for CynergisTek
.

How were CynergisTek's earnings last quarter?

CynergisTek Inc (NYSEAMERICAN:CTEK) posted its quarterly earnings results on Thursday, August, 13th. The company reported ($0.23) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.11) by $0.12. The business had revenue of $4.56 million for the quarter.
View CynergisTek's earnings history
.

What price target have analysts set for CTEK?

1 analysts have issued 12 month target prices for CynergisTek's shares. Their forecasts range from $4.00 to $4.00. On average, they expect CynergisTek's share price to reach $4.00 in the next year. This suggests a possible upside of 288.3% from the stock's current price.
View analysts' price targets for CynergisTek
.

Are investors shorting CynergisTek?

CynergisTek saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 65,600 shares, an increase of 260.4% from the August 15th total of 18,200 shares. Based on an average trading volume of 157,700 shares, the short-interest ratio is currently 0.4 days. Approximately 0.7% of the shares of the stock are sold short.
View CynergisTek's Short Interest
.

Who are some of CynergisTek's key competitors?

What other stocks do shareholders of CynergisTek own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CynergisTek investors own include AcelRx Pharmaceuticals (ACRX), SeaChange International (SEAC), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Invesco (IVZ), Matinas BioPharma (MTNB), OpGen (OPGN), Opko Health (OPK), VBI Vaccines (VBIV) and Vaxart (VXRT).

Who are CynergisTek's key executives?

CynergisTek's management team includes the following people:
  • Mr. Michael H. McMillan CISM, FHIMSS, CEO, Pres, Chief Strategy Officer & Director (Age 62)
  • Mr. Paul T. Anthony, CFO, Corp. Sec. & Treasurer (Age 48)
  • Mr. Bryan Flynn, Head of Investor Relations
  • Mr. Jon Hilfiger, Sr. VP of Sales & Marketing
  • Mr. Jeremy Molnar, Sr. VP of Security Services

What is CynergisTek's stock symbol?

CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."

Who are CynergisTek's major shareholders?

CynergisTek's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Bridgeway Capital Management Inc. (2.73%). Company insiders that own CynergisTek stock include Dana Davis Sellers, John D Abouchar, Judith Finger Krandel, Mark D Roberson, Paul Thomas Anthony, Robert Mccashin and William Caleb Barlow.
View institutional ownership trends for CynergisTek
.

Which major investors are buying CynergisTek stock?

CTEK stock was bought by a variety of institutional investors in the last quarter, including Bridgeway Capital Management Inc.. Company insiders that have bought CynergisTek stock in the last two years include Dana Davis Sellers, John D Abouchar, Judith Finger Krandel, Mark D Roberson, Paul Thomas Anthony, Robert Mccashin, and William Caleb Barlow.
View insider buying and selling activity for CynergisTek
.

How do I buy shares of CynergisTek?

Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CynergisTek's stock price today?

One share of CTEK stock can currently be purchased for approximately $1.03.

How big of a company is CynergisTek?

CynergisTek has a market capitalization of $10.91 million. CynergisTek employs 292 workers across the globe.

What is CynergisTek's official website?

The official website for CynergisTek is www.cynergistek.com.

How can I contact CynergisTek?

The company can be reached via phone at 949-614-0700.

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.